Evidence map›Paper›PMID 27581454›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength.

Magali H Arons, Kevin Lee, Charlotte J Thynne, Sally A Kim, Claudia Schob, Stefan Kindler, Johanna M Montgomery, Craig C Garner

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Differential effectiveness of dietary zinc supplementation with autism-related behaviours inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. The Role of Zinc and NMDA Receptors in Autism Spectrum Disorders.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Neuromotor Development in theBrain sciences · 2022
    Article
  15. Prenatal Zinc Deficient Mice as a Model for Autism Spectrum Disorders.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Magali H AronsDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California 94305.
Kevin LeeDepartment of Physiology, University of Auckland, Auckland 92019, New Zealand.ORCID 0000-0002-8385-4786
Charlotte J ThynneDepartment of Physiology, University of Auckland, Auckland 92019, New Zealand.
Sally A KimDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California 94305.ORCID 0000-0001-7790-4065
Claudia SchobInstitute for Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany, and.
Stefan KindlerInstitute for Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany, and.
Johanna M MontgomeryDepartment of Physiology, University of Auckland, Auckland 92019, New Zealand, craig-curtis.garner@dzne.de jm.montgomery@auckland.ac.nz.ORCID 0000-0002-8714-7456
Craig C GarnerDepartment of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California 94305, German Centers for Neurodegenerative Disorders, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany craig-curtis.garner@dzne.de jm.montgomery@auckland.ac.nz.
Stanford University · USUniversity of Auckland · NZUniversity Medical Center Hamburg-Eppendorf · DE

Funding

Solid-state patch clamp platform to diagnose autism and screen for effective drugR33MH100717 · NIMH · STANFORD UNIVERSITY · PI HUGUENARD, JOHN R · 2016 to 2017
$778k
Solid-state patch clamp platform to diagnose autism and screen for effective drugR21MH100717 · NIMH · STANFORD UNIVERSITY · PI HUGUENARD, JOHN R · 2013 to 2014
$427k
NIMH NIH HHS R21 MH100717NIMH NIH HHS R33 MH100717
6 · The paper itself

Abstract

unlabelledShank3 is a multidomain scaffold protein localized to the postsynaptic density of excitatory synapses. Functional studies in vivo and in vitro support the concept that Shank3 is critical for synaptic plasticity and the trans-synaptic coupling between the reliability of presynaptic neurotransmitter release and postsynaptic responsiveness. However, how Shank3 regulates synaptic strength remains unclear. The C terminus of Shank3 contains a sterile alpha motif (SAM) domain that is essential for its postsynaptic localization and also binds zinc, thus raising the possibility that changing zinc levels modulate Shank3 function in dendritic spines. In support of this hypothesis, we find that zinc is a potent regulator of Shank3 activation and dynamics in rat hippocampal neurons. Moreover, we show that zinc modulation of synaptic transmission is Shank3 dependent. Interestingly, an autism spectrum disorder (ASD)-associated variant of Shank3 (Shank3(R87C)) retains its zinc sensitivity and supports zinc-dependent activation of AMPAR-mediated synaptic transmission. However, elevated zinc was unable to rescue defects in trans-synaptic signaling caused by the R87C mutation, implying that trans-synaptic increases in neurotransmitter release are not necessary for the postsynaptic effects of zinc. Together, these data suggest that Shank3 is a key component of a zinc-sensitive signaling system, regulating synaptic strength that may be impaired in ASD. SIGNIFICANCE STATEMENT: Shank3 is a postsynaptic protein associated with neurodevelopmental disorders such as autism and schizophrenia. In this study, we show that Shank3 is a key component of a zinc-sensitive signaling system that regulates excitatory synaptic transmission. Intriguingly, an autism-associated mutation in Shank3 partially impairs this signaling system. Therefore, perturbation of zinc homeostasis may impair, not only synaptic functionality and plasticity, but also may lead to cognitive and behavioral abnormalities seen in patients with psychiatric disorders.

Indexed as

AnimalsCells, CulturedChelating AgentsChloridesDendritic SpinesDose-Response Relationship, DrugEmbryo, MammalianEthylenediaminesExcitatory Postsynaptic PotentialsFemaleGreen Fluorescent ProteinsHippocampusHomer Scaffolding ProteinsMaleMutationNerve Tissue ProteinsChelating AgentsChloridesenhanced green fluorescent proteinEthylenediaminesGreen Fluorescent ProteinsHomer Scaffolding ProteinsNerve Tissue ProteinsN,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamineReceptors, AMPARNA, Small InterferingShank3 protein, ratSlc17a7 protein, ratVesicular Glutamate Transport Protein 1Zinczinc chlorideZinc Compoundshippocampuspostsynaptic densityShank3zinc

Identifiers

PMID27581454
PMCPMC5005722
OpenAlexW2510646175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.